Detalhe da pesquisa
1.
Performance of Clostridioides difficile infection severity scores and risk factors related to 30-day all-cause mortality in patients with cancer.
Support Care Cancer
; 31(3): 187, 2023 Feb 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36843052
2.
Prevalence of SARS-CoV-2 antibodies in cancer patients and healthcare workers vaccinated with two doses of BNT162b2 or AZD122. A propensity analysis.
Gac Med Mex
; 159(4): 287-295, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37699227
3.
Molecular characterization and genotyping of isolates from cancer patients with Clostridioides difficile infection or asymptomatic colonization.
J Med Microbiol
; 72(8)2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37624363
4.
Systemic Anticancer Therapy and Thromboembolic Outcomes in Hospitalized Patients With Cancer and COVID-19.
JAMA Oncol
; 9(10): 1390-1400, 2023 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37589970
5.
Risk factors and clinical outcomes for Clostridioides difficile infections in a case control study at a large cancer referral center in Mexico.
Am J Infect Control
; 50(11): 1220-1225, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-35172185
6.
Clinical characteristics and outcomes in a cohort of oncologic patients with COVID-19 during the first year of the pandemic in Mexico.
Cancer Med
; 11(8): 1827-1836, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35166033
7.
Vaccination Status and Other Preventive Measures in Medical Schools. Big Needs and Opportunities.
Arch Med Res
; 49(4): 255-260, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30195701